Cetirizine Safety in Infants

Age-Specific Safety Thresholds

The American Academy of Pediatrics recommends that cetirizine should not be given to infants under 6 months of age due to lack of safety data and regulatory restrictions, but it is safe and well-tolerated in infants 6 months and older at a dose of 0.25 mg/kg twice daily 1, 2
Infants 6-11 months can use cetirizine at 0.25 mg/kg twice daily, with a mean dose approximately 4.5 mg/day 2
The critical age cutoff is 6 months, which represents a clinically meaningful safety boundary, and guidelines specifically require consulting product labeling before prescribing in this age range 1, 2

Historical fatality data shows that between 1969-2006, antihistamines caused 69 deaths in children under 6 years, with 41 deaths occurring in children under 2 years 2
The FDA advisory position recommends against OTC cough/cold medications in children under 6 years due to safety concerns 2

The American Academy of Pediatrics recommends non-pharmacologic approaches first, such as allergen avoidance and supportive care, as the primary strategy for managing allergic symptoms in infants under 6 months 1, 3
Intranasal corticosteroids are the most effective medication class for allergic rhinitis symptoms in children under 2 years, controlling all four major symptoms (sneezing, itching, rhinorrhea, nasal congestion) 2

The standard dose of cetirizine for infants 6 months and older is 0.25 mg/kg twice daily 2
In cases of renal impairment, the dose should be reduced by 50% in moderate renal impairment (creatinine clearance 10-20 mL/min) and avoided entirely in severe renal impairment (creatinine clearance <10 mL/min) 1, 3, 4

The American Academy of Pediatrics advises against assuming all second-generation antihistamines are equally safe, and age-appropriate safety data must be considered for each specific agent 1
Combining cetirizine with sedating medications should be avoided due to additive CNS depression effects 1, 3